You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Post Swine Flu Blood Samples

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis Infection Trial in Saint Petersburg (TB/Flu-05E vaccine, Placebo)

Active, not recruiting
  • Tuberculosis Infection
  • TB/Flu-05E vaccine
  • Placebo
  • Saint Petersburg, Russian Federation
    Smorodintsev Research Institute of Influenza
Jul 11, 2023

Hypovolemic Shock Trial in India (Centhaquine)

Recruiting
  • Hypovolemic Shock
  • Nellore, Andhra Pradesh, India
  • +16 more
Jul 13, 2023

Influenza, COVID-19, Influenza Immunogencity Trial in United States (Simultaneous Vaccination (Influenza Vaccine and mRNA COVID

Not yet recruiting
  • Influenza
  • +3 more
  • Simultaneous Vaccination (Influenza Vaccine and mRNA COVID booster)
  • +2 more
  • Phoenix, Arizona
  • +7 more
Aug 30, 2023

Inflammatory Response Trial (Blueberry-protein gel, Blueberry gel, Placebo)

Not yet recruiting
  • Inflammatory Response
  • Blueberry-protein gel
  • +2 more
  • (no location specified)
Oct 24, 2022

Advanced NSCLC Trial in China (Gene Profile explore)

Recruiting
  • Advanced NSCLC
  • Gene Profile explore
  • Beijing, China
  • +14 more
Jan 27, 2023

Influenza, Human Trial in Birmingham (Treatment Group Live Attenuated Flu Vaccine (LAIV))

Completed
  • Influenza, Human
  • Treatment Group Live Attenuated Flu Vaccine (LAIV)
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 16, 2022

Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

Recruiting
  • Hematopoietic Malignancy
  • +2 more
  • Umbilical Cord Blood Transplantation
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow university
Nov 6, 2023

The Immu-KNEE-ty Study

Not yet recruiting
  • Immunosenescence
  • Aging
  • Knee arthroplasty
  • Ede, Netherlands
    Gelderse Vallei Hospital
Jun 15, 2023

Healthy Trial in Herlev (Exercise)

Recruiting
  • Healthy
  • Exercise
  • Herlev, Denmark
    Herlev Hospital
Apr 24, 2023

Influenza, Influenza, Human, Influenza Viral Infections Trial in Russian Federation (Influenza vaccine [inactivated])

Recruiting
  • Influenza
  • +3 more
  • Influenza vaccine [inactivated]
  • Ekaterinburg, Russian Federation
  • +6 more
Feb 13, 2023

Immune Defect Trial in Miami (Fluzone Quadrivalent)

Recruiting
  • Immune Defect
  • Fluzone Quadrivalent
  • Miami, Florida
    University of Miami
Oct 17, 2022

Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
    • (no location specified)
    Nov 1, 2023

    End-stage Renal Disease Trial in Ghent (High volume post dilution hemodiafiltration, high flux hemodialysis)

    Completed
    • End-stage Renal Disease
    • High volume post dilution hemodiafiltration
    • high flux hemodialysis
    • Ghent, Belgium
      University Hospital Ghent
    Dec 13, 2022

    Respiratory Virus Hospitalization Study (FLU 003 Plus)

    Recruiting
    • Influenza
    • +2 more
      • San Diego, California
      • +62 more
      Mar 28, 2022

      Influenza Trial in Novosibirsk, Perm, Saint Petersburg (Flu-M [Inactivated split influenza vaccine], Inactivated influenza split

      Completed
      • Influenza
      • Flu-M [Inactivated split influenza vaccine]
      • Inactivated influenza split vaccine
      • Novosibirsk, Russian Federation
      • +2 more
      Mar 16, 2022

      Influenza, Immunization, Older Adults Trial in Baltimore (Influenza)

      Recruiting
      • Influenza
      • +3 more
      • Influenza
      • Baltimore, Maryland
        Johns Hopkins University; JHAAC 5501 Hopkins Bayview Circle, 1B8
      Mar 14, 2022

      Gut Microbiota and Immune Response to Influenza Vaccine

      Not yet recruiting
      • Inflammatory Bowel Diseases
      • Influenza vaccine
      • (no location specified)
      Oct 19, 2022

      Inflammatory Response, Muscular Injury Trial in Kannapolis (Mangoes, Water)

      Recruiting
      • Inflammatory Response
      • Muscular Injury
      • Mangoes
      • Water
      • Kannapolis, North Carolina
        Appalachian State University Human Performance Lab, North Caroli
      Oct 24, 2022

      Influenza Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (VRC-FLUMOS0116-00-VP( FLUMos-v2))

      Recruiting
      • Influenza
      • VRC-FLUMOS0116-00-VP( FLUMos-v2)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 4, 2023

      Influenza Infection Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (A/Mallard/Ohio-99/MM4/1989

      Not yet recruiting
      • Influenza Infection
      • A/Mallard/Ohio-99/MM4/1989 H10N7
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 17, 2022

      Characterisation of the Immune Response to SARS-CoV-2 / COVID-19

      Recruiting
      • Covid19
      • blood test
      • Llantrisant, Rhondda Cynon Taf, United Kingdom
        Cwm Taf Morgannwg University Health board
      May 25, 2022

      Healthy Individuals, Bioequivalence Study Trial in Karachi (Moxifloxacin 400mg)

      Completed
      • Healthy Individuals
      • Bioequivalence Study
      • Moxifloxacin 400mg
      • Karachi, Sindh, Pakistan
        Center for Bioequivalence Studies and clinical research
      Sep 5, 2022

      Influenza, Human, Vaccination; Infection, Vaccines Trial in Russian Federation (Flu-M, Inactivated split influenza vaccine,

      Completed
      • Influenza, Human
      • +2 more
      • Flu-M, Inactivated split influenza vaccine
      • Ultrix®, Inactivated Split Influenza Vaccine
      • Barnaul, Altai Territory, Russian Federation
      • +4 more
      Jul 11, 2022

      Healthy, Bioequivalence Study Trial in Karachi (Dexlansoprazole)

      Recruiting
      • Healthy
      • Bioequivalence Study
      • Karachi, Sindh, Pakistan
        Center for Bioequivalence Studies and clinical research
      Sep 5, 2022

      Respiratory Syncytial Virus Infections Trial in New Zealand, Panama, South Africa (RSVPreF3 OA investigational vaccine, FLU-QIV)

      Completed
      Has Results
      • Respiratory Syncytial Virus Infections
      • RSVPreF3 OA investigational vaccine
      • FLU-QIV
      • Auckland, New Zealand
      • +13 more
      Sep 20, 2022